First Trust Advisors LP grew its holdings in Dolby Laboratories (NYSE:DLB – Free Report) by 19.9% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 2,254,933 shares of the electronics maker’s stock after acquiring an additional 374,405 shares during the period. First Trust Advisors LP’s holdings in Dolby Laboratories were worth $135,431,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Johnson Financial Group Inc. raised its position in shares of Dolby Laboratories by 23.0% during the 1st quarter. Johnson Financial Group Inc. now owns 16,414 shares of the electronics maker’s stock valued at $986,000 after buying an additional 3,074 shares in the last quarter. Meeder Advisory Services Inc. bought a new position in shares of Dolby Laboratories in the 1st quarter valued at about $260,000. WCM Investment Management LLC purchased a new position in Dolby Laboratories in the first quarter worth about $716,000. Dimensional Fund Advisors LP grew its position in Dolby Laboratories by 6.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,321,407 shares of the electronics maker’s stock worth $79,357,000 after acquiring an additional 83,835 shares in the last quarter. Finally, Gallacher Capital Management LLC grew its position in Dolby Laboratories by 43.1% in the first quarter. Gallacher Capital Management LLC now owns 8,557 shares of the electronics maker’s stock worth $514,000 after acquiring an additional 2,577 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In related news, CFO Robert J. Park sold 4,895 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total transaction of $277,448.60. Following the completion of the sale, the chief financial officer directly owned 81,490 shares of the company’s stock, valued at approximately $4,618,853.20. This trade represents a 5.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $54.90, for a total value of $164,700.00. Following the transaction, the senior vice president owned 80,603 shares of the company’s stock, valued at approximately $4,425,104.70. The trade was a 3.59% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 47,458 shares of company stock worth $2,639,537. Corporate insiders own 37.93% of the company’s stock.
Analyst Ratings Changes
View Our Latest Stock Report on DLB
Dolby Laboratories Trading Down 0.0%
Dolby Laboratories stock opened at $49.11 on Friday. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $76.70. The firm has a 50-day moving average price of $52.44 and a 200-day moving average price of $59.02. The firm has a market capitalization of $4.65 billion, a PE ratio of 19.41 and a beta of 0.81.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. During the same period in the prior year, the firm posted $1.34 EPS. The firm’s revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, sell-side analysts predict that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.
Dolby Laboratories Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.9%. Dolby Laboratories’s dividend payout ratio is currently 56.92%.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
